Free Trial

Q2 EPS Estimates for Vitalhub Cut by Raymond James Financial

Vitalhub logo with Medical background

Vitalhub Corp. (TSE:VHI - Free Report) - Stock analysts at Raymond James Financial cut their Q2 2025 EPS estimates for shares of Vitalhub in a research note issued to investors on Wednesday, July 9th. Raymond James Financial analyst M. Freeman now anticipates that the company will earn $0.04 per share for the quarter, down from their prior estimate of $0.05. Raymond James Financial currently has a "Outperform" rating and a $14.00 target price on the stock. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share.

Several other research firms have also recently weighed in on VHI. National Bank Financial upgraded shares of Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. TD Securities increased their price objective on shares of Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a research report on Monday, March 31st. Scotiabank increased their price objective on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research report on Friday, June 20th. Finally, National Bankshares set a C$14.00 price objective on shares of Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. Six equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Vitalhub presently has a consensus rating of "Buy" and an average target price of C$13.25.

Get Our Latest Report on Vitalhub

Vitalhub Price Performance

Shares of VHI traded down C$0.08 during trading hours on Friday, hitting C$12.45. 204,008 shares of the stock were exchanged, compared to its average volume of 127,570. Vitalhub has a fifty-two week low of C$6.74 and a fifty-two week high of C$12.72. The business has a 50-day moving average of C$10.86 and a 200-day moving average of C$10.61. The firm has a market capitalization of C$673.45 million, a P/E ratio of 202.49, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26.

Insider Transactions at Vitalhub

In related news, Director Francis Nelson Shen bought 25,000 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is currently owned by corporate insiders.

Vitalhub Company Profile

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Read More

Earnings History and Estimates for Vitalhub (TSE:VHI)

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines